Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-11-26
2011-11-22
Lewis, Patrick (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S042000, C514S043000, C514S045000, C514S049000, C514S050000, C514S051000, C514S052000
Reexamination Certificate
active
08063025
ABSTRACT:
Compounds having the formula I or II wherein R1, R2, B, and V are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
REFERENCES:
patent: 2005/0075309 (2005-04-01), Storer et al.
patent: 2007/0021388 (2007-01-01), Reddy et al.
patent: WO 2006/033709 (2006-03-01), None
Supplementary European Search Report issued in EP Appln. 08855731.9 on Feb. 28, 2011.
Bookser Brett C.
Hecker Scott J.
Reddy K. Raja
Smith David Bernard
Sun Zhili
Arnold & Porter LLP
Lewis Patrick
Metabasis Therapeutics, Inc.
LandOfFree
Nucleoside prodrugs and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleoside prodrugs and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleoside prodrugs and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4264777